BackEstrella Immunopharma Overview

Estrella Immunopharma Other Current Assets

Track Estrella Immunopharma's other current assets ($1.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.68M
923.60% YoYΔ $1.51M vs prior year quarter

Peer average / median

Loading

Estrella Immunopharma Other Current Assets History

Loading

Estrella Immunopharma vs. peers: Other Current Assets Comparison

Loading

Estrella Immunopharma Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Estrella Immunopharma (ESLA) FAQ

As of the most recent data (June 2026), ESLA shows a other current assets of $1.7M. That compares with $160K in the prior-year period — up 923.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ESLA's other current assets is now $1.7M (was $160K) — a 923.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Estrella Immunopharma is outperforming or lagging.

Tracking ESLA's other current assets over time shows whether Estrella Immunopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M That compares with $160K in the prior-year period — up 923.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Estrella Immunopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.7M) with ownership activity and broader fundamentals.